MoneyTree™ Life Sciences Report

November 2014
  • Print-friendly version
MoneyTree™ Life Sciences Report

At a glance

Investments in both the biotech and medical devices industries have continued to increase year-over-year. However, investments for the two industries declined compared to the exceptionally strong last quarter, which saw record high investments in biotech.

Regional funding trends: During the third quarter of 2014, San Francisco Bay, Boston, San Diego Metro, Seattle, and Orange County, received the most life sciences venture capital dollars.

The leader, San Francisco Bay, received $499 million, with $281 million going into biotechnology and the remaining $218 million going to medical devices. The San Francisco Bay area closed 42 deals during the third quarter of 2014, with an average deal size of $11.9 million.

Further reading

MoneyTree™ venture capital funding: Biotech soars to record high
MoneyTree™ venture capital funding: Biotech deals rising
MoneyTree™ venture capital funding: Falling behind
MoneyTree™ venture capital funding: Biotech boost